Grantham, Mayo, Van Otterloo & Co (GMO)’s Ambev ABEV Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Buy	+807,600	New	+$2.52M	0.01%	409
2025 Q3	–	Sell	-2,385,900	Closed	-$5.75M	–	601
2025 Q2	$5.75M	Buy	2,385,900 +2,367,600	+12,938%	+$5.76M	0.02%	279
2025 Q1	$42.6K	Buy	+18,300	New	+$36.6K	﹤0.01%	611
2024 Q2	–	Sell	-37,500	Closed	-$93K	–	527
2024 Q1	$93K	Hold	37,500	–	–	﹤0.01%	508
2023 Q4	$105K	Sell	37,500 -20,200	-35%	-$54.6K	﹤0.01%	480
2023 Q3	$149K	Buy	57,700 +37,500	+186%	+$108K	﹤0.01%	564
2023 Q2	$64.2K	Hold	20,200	–	–	﹤0.01%	668
2023 Q1	$57K	Sell	20,200 -88,900	-81%	-$233K	﹤0.01%	686
2022 Q4	$297K	Buy	+109,100	New	+$318K	﹤0.01%	634
2022 Q2	–	Sell	-196,100	Closed	-$633K	–	738
2022 Q1	$633K	Sell	196,100 -98,700	-33%	-$276K	﹤0.01%	575
2021 Q4	$825K	Buy	+294,800	New	+$845K	﹤0.01%	559
2019 Q4	–	Sell	-997,258	Closed	-$4.61M	–	674
2019 Q3	$4.61M	Buy	997,258 +51,000	+5%	+$244K	0.03%	309
2019 Q2	$4.42M	Sell	946,258 -244,700	-21%	-$1.1M	0.03%	321
2019 Q1	$5.12M	Sell	1,190,958 -210,100	-15%	-$965K	0.04%	268
2018 Q4	$5.49M	Sell	1,401,058 -6,140,700	-81%	-$26.2M	0.04%	178
2018 Q3	$34.5M	Buy	7,541,758 +810,958	+12%	+$3.87M	0.23%	75
2018 Q2	$31.2M	Buy	+6,730,800	New	+$39.5M	0.22%	69
2016 Q4	–	Sell	-16,700	Closed	-$102K	–	499
2016 Q3	$102K	Sell	16,700 -310,500	-95%	-$1.86M	﹤0.01%	492
2016 Q2	$1.93M	Buy	327,200 +96,500	+42%	+$518K	0.01%	365
2016 Q1	$1.2M	Sell	230,700 -129,600	-36%	-$596K	﹤0.01%	408
2015 Q4	$1.61M	Buy	360,300 +201,200	+126%	+$983K	0.01%	348
2015 Q3	$780K	Buy	159,100 +119,700	+304%	+$650K	﹤0.01%	428
2015 Q2	$240K	Buy	+39,400	New	+$243K	﹤0.01%	426
2014 Q2	–	Sell	-1,944,600	Closed	-$14.4M	–	490
2014 Q1	$14.4M	Sell	1,944,600 -209,700	-10%	-$1.47M	0.04%	176
2013 Q4	$15.8M	Buy	+2,154,300	New	+$15.7M	0.04%	167

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ABEV Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Ambev (ABEV) in Q2 2026: 807,600 shares worth $2.54M. The stake represents 0.01% of the portfolio and ranks #409 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in ABEV as recently as Q2 2025.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ABEV in Q4 2013 and has held it in 25 quarters since. The position peaked at $34.5M in Q3 2018. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 807,600 shares of Ambev worth $2.54M as of Q2 2026.
Ambev was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q2 2026.
Ambev made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #409 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ambev in Q4 2013 and has held it in 25 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Ambev position peaked at $34.5M in Q3 2018.
404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.